Patent ID: 8568748

Claim:
A method of treatment of inflammatory skin and mucous membrane diseases, comprising the step of topical application of a pharmaceutical formulation in colloidal form to a patient, said pharmaceutical formulation comprising: a) a lipophilic phase in a quantity of 1-10% by weight, b) a mixture of surfactant, wherein the surfactant comprises polyoxyethylene glycerol fatty acid esters, and co-surfactant, wherein the co-surfactant comprises poloxamers in a quantity of 1-50% by weight, the surfactant/co-surfactant mixture being used in a mass ratio of 2 for the surfactant and 3 for the co-surfactant, c) a hydrophilic phase in a quantity of 40-80% by weight, and d) as active ingredient, cyclosporin, in a concentration of 0.1-20% by weight.